Biotech by today's price change

How far the share price has moved since the previous close.

Repligen leads the 24 biotech ranked by today's price change, at +5.00%, ahead of Scholar Rock Holding (+4.43%) and CRISPR Therapeutics (+3.06%). Figures as of 18 Nov 2026, 14:51 UTC, from Yahoo Finance quotes.

Key facts

Companies ranked
24
First
Repligen+5.00%
Median
-0.13%
Combined market value
ZAR 14.48T
Countries
5

Market values as of .

Biotech by today's price change
#CompanyToday ↓Market capPriceToday1 yearPrice, 30 daysCountry
1RepligenRGEN · Health Care+5.00%ZAR 187.2BZAR 2,929.09 5.00% up 5% up United States
2Scholar Rock HoldingSRRK · Health Care+4.43%ZAR 98.8BZAR 809.74 4.43% up 14% up United States
3CRISPR TherapeuticsCRSP · Health Care+3.06%ZAR 69BZAR 711.78 3.06% up 21% down Switzerland
4Krystal BiotechKRYS · Health Care+1.52%ZAR 154.5BZAR 5,213.40 1.52% up 46% up United States
5Twist BioscienceTWST · Health Care+1.20%ZAR 132.9BZAR 1,949.57 1.20% up 340% up United States
6argenxARGX · Health Care+1.07%ZAR 1.04TZAR 16,473.49 1.07% up 4% up Belgium
7ImmunovantIMVT · Health Care+0.38%ZAR 118.7BZAR 573.40 0.38% up 43% up United States
8Kymera TherapeuticsKYMR · Health Care+0.25%ZAR 178.9BZAR 2,095.44 0.25% up 87% up United States
9Bio-TechneTECH · Health Care+0.14%ZAR 196.5BZAR 1,251.04 0.14% up 26% up United States
10ExelixisEXEL · Health Care+0.09%ZAR 287.8BZAR 1,179.31 0.09% up 63% up United States
11BiogenBIIB · Health Care-0.10%ZAR 637.1BZAR 4,309.74 0.10% down 49% up United States
12Halozyme TherapeuticsHALO · Health Care-0.13%ZAR 188BZAR 1,648.64 0.13% down 37% up United States
13QiagenQGEN · Health Care-0.13%ZAR 176.5BZAR 854.64 0.13% down 12% up Netherlands
14BioNTechBNTX · Health Care-0.20%ZAR 361.2BZAR 1,456.76 0.20% down 16% down Germany
15Adaptive BiotechnologiesADPT · Health Care-0.35%ZAR 79.1BZAR 488.34 0.35% down 88% up United States
16Kodiak SciencesKOD · Health Care-0.41%ZAR 108.4BZAR 1,658.19 0.41% down 396% up United States
17Gilead SciencesGILD · Health Care-0.68%ZAR 3.61TZAR 2,908.88 0.68% down 33% up United States
18Neurocrine BiosciencesNBIX · Health Care-0.72%ZAR 286.8BZAR 2,833.37 0.72% down 20% up United States
19VaxcytePCVX · Health Care-1.09%ZAR 160BZAR 1,010.56 1.09% down 22% up United States
20CG OncologyCGON · Health Care-1.12%ZAR 119.9BZAR 1,342.63 1.12% down 85% up United States
21ImmunityBioIBRX · Health Care-1.76%ZAR 112.5BZAR 105.79 1.76% down 193% up United States
22AmgenAMGN · Health Care-1.85%ZAR 4.18TZAR 7,731.55 1.85% down 34% up United States
23ModernaMRNA · Health Care-2.08%ZAR 1.41TZAR 3,483.31 2.08% down 755% up United States
24Revolution MedicinesRVMD · Health Care-2.52%ZAR 590BZAR 2,728.01 2.52% down 131% up United States

Sources: share prices and market values from Yahoo Finance; sector, country and category from each company's SEC registration.

Market value is share price × shares outstanding, from Yahoo Finance; prices may be delayed 15 minutes or more and the ranking refreshes about every 20 minutes. The list covers companies with shares listed in the US, which includes foreign companies listed through ADRs but not ones listed only abroad. Sector, category and country come from each company's SEC registration. Sums are converted from US dollars at today's exchange rate (1 USD = 17.2011 ZAR).

Questions and answers

Which biotech rank first by today's price change?

Repligen (+5.00%), Scholar Rock Holding (+4.43%) and CRISPR Therapeutics (+3.06%) are the top three of the 24 biotech ranked by today's price change as of 18 Nov 2026, 14:51 UTC.

How many biotech are in this ranking?

24 are ranked by today's price change.

What are these biotech worth together?

The 24 biotech ranked by today's price change have a combined market value of ZAR 14.48T as of 18 Nov 2026, 14:51 UTC.

What does ranking by today's price change measure?

How far the share price has moved since the previous close.

Cite this page

Funkfolio, “Biotech by today's price change”, data as of 18 November 2026. https://funkfolio.com/companies/category/biotech?by=day-change

Underlying data: Yahoo Finance; SEC EDGAR.